Lack of Gender Differences and Large Intrasubject Variability in Cytochrome P450 Activity Measured by Phenotyping with Dextromethorphan

Goodman & Gilman's The Pharmacological Basis of Therapeutics

1985 • 7,054 citations

Goodman and Gilman's the Pharmacological Basis of Therapeutics

1986 • 6,964 citations

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature

1996 • 2,895 citations

Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors

1997 • 1,161 citations

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*

1996 • 598 citations

Gender Effects in Pharmacokinetics and Pharmacodynamics

1995 • 495 citations

Effect of age and gender on the activity of human hepatic CYP3A

1992 • 425 citations

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin*

1998 • 404 citations

Induction of CYP2D6 in pregnancy*

1997 • 216 citations

Impaired elimination of caffeine by oral contraceptive steroids.

1980 • 177 citations

Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics

1993 • 167 citations

Menstrual cycle effects on caffeine elimination in the human female

1992 • 157 citations

CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans

1993 • 143 citations

DEMOGRAPHIC FACTORS AFFECTING THE PHARMACOKINETICS OF CYCLOSPORINE ESTIMATED BY RADIOIMMUNOASSAY

1986 • 128 citations

Gender differences in human pharmacokinetics and pharmacodynamics

1994 • 119 citations

Intersubject and dose‐related variability after intravenous administration of erythromycin.

1980 • 112 citations

Simultaneous Determination of Dextromethorphan and Three Metabolites in Plasma and Urine Using High-Performance Liquid Chromatography with Application to Their Disposition in Man

1990 • 112 citations

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam*

1998 • 107 citations

Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics

1984 • 104 citations

Multiple Human Cytochromes Contribute to Biotransformation of Dextromethorphan In-vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A

1998 • 100 citations

Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype

1996 • 82 citations

Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity

1996 • 81 citations

Metabolism of Dextromethorphanin vitro: Involvement of Cytochromes P450 2D6 AND 3A3/4, with a Possible Role of 2E1

1997 • 81 citations

Inhibition of oral contraceptive steroid—metabolizing enzymes by steroids and drugs

1990 • 79 citations

Effect of age and gender on tirilazad pharmacokinetics in humans

1994 • 75 citations

Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping

1998 • 67 citations

Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation*

1996 • 67 citations

Influence of menstrual cycle and gender on alprazolam pharmacokinetics

1991 • 61 citations

Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activity

1996 • 54 citations

Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes

1991 • 54 citations

Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics

1990 • 51 citations

Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics*

1996 • 50 citations

Impairment of antipyrine metabolism by low-dose oral contraceptive steroids

1981 • 48 citations

Menstrual Cycle Variability in Midazolam Pharmacokinetics

1999 • 45 citations

Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women

1978 • 38 citations

Antipyrine metabolism during the menstrual cycle

1980 • 38 citations

Phenotypic differences in dextromethorphan metabolism.

1989 • 32 citations

Cytochrome P450 3A4 activity in premenopausal and postmenopausal women, based on 6-beta-hydroxycortisol:cortisol ratios.

1998 • 31 citations

Alterations in prednisolone disposition as a result of oral contraceptive use and dose.

1984 • 30 citations

Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?

1998 • 29 citations

Aging and alfentanil disposition in healthy volunteers and surgical patients

1989 • 24 citations

Cytochrome P450 3A4 Activity in Premenopausal and Postmenopausal Women, Based on 6‐β‐Hydroxycortisol:Cortisol Ratios

1998 • 23 citations

Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio.

1988 • 23 citations

Antipyrine elimination in saliva after low-dose combined or progestogen- only oral contraceptive steroids.

1982 • 16 citations

Effect of steroids on the cytochrome P4502D6-catalysed metabolism of metoprolol

1991 • 11 citations

Urinary excretion of 6β-hydroxycortisol in women during treatment with different oral contraceptive formulations

1995 • 9 citations

Deleted Work

1955 • 0 citations